US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% SNDK $1,704.16 ▼-0.92%
FinancialContent

IRIDEX Corporation - Common Stock (NQ:IRIX)

0.6900 +0.0500 (+7.81%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Iridex Appoints Patrick Mercer as Chief Executive Officer
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Iridex Reports Second Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Convertible Note Financing
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Iridex Reports First Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex's Earnings Outlook ↗
 
Via Benzinga
News headline image
Iridex: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For March 26, 2024 ↗
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
News headline image
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Corporation Receives European Patent on MicroPulse Technology
The Advanced Short Pulse Laser System 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Third Quarter 2023 Financial Results and Business Update
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
The Company also announced plans to present at Stifel Healthcare Conference 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged ↗
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded up 0.40% to 33,185.41 while the NASDAQ rose 0.92% to 12,969.54. The S&P 500... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow traded up 0.55% to 33,233.33 while the NASDAQ rose 0.87% to 12,962.92. The... 
Via Benzinga
Topics Economy Stocks
News headline image
US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected ↗
U.S. stocks traded mixed this morning, ahead of interest rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.05% to 33,036.63 while the NASDAQ rose... 
Via Benzinga
Topics Economy Stocks
< Previous 1 2 3 4 5 Next >